These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats. Vemulapalli S, Chiu PJ, Brown A, Griscti K, Sybertz EJ. Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942 [Abstract] [Full Text] [Related]
5. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor. Sybertz EJ, Chiu PJ, Vemulapalli S, Watkins R, Haslanger MF. Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404 [Abstract] [Full Text] [Related]
6. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats. Sala C, Monopoli A, Casati C, Ardeleani G, Ongini E, Zanchetti A, Morganti A. J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451 [Abstract] [Full Text] [Related]
8. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats. Vemulapalli S, Watkins RW, Brown A, Cook J, Bernardino V, Chiu PJ. Life Sci; 1993 May; 53(10):783-93. PubMed ID: 8355566 [Abstract] [Full Text] [Related]
9. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. Kukkonen P, Vuolteenaho O, Ruskoaho H. Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129 [Abstract] [Full Text] [Related]
10. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension. Kohzuki M, Abe K, Yasujima M, Kasai Y, Hiwatari M, Kanazawa M, Sato M, Omata K, Kudo K, Takeuchi K. Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826 [Abstract] [Full Text] [Related]